FOLH1 and bladder adenocarcinoma: Based on an immunohistochemical study showing PSMA expression in urothelial BCa, some authors hypothesized that PSMA expression in adenocarcinoma of the urinary bladder can be demonstrated in vivo using 68 Ga-PSMA-11PET/CT19.